Is a surgical resection leaving positive margins of benefit to the patient with locally-advanced squamous cell carcinoma of the head and neck?
โ Scribed by G.E. Laramore; C.B. Scott; D.E. Schuller; R.E. Haselow; T.J. Ervin; R. Wheeler; M. Al-Sarraf; R.A. Gahbauer; J.R. Jacobs; J.G. Schwade; B.H. Campbell
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 107 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. Postopertative adjuvant chemoradiotherapy recently became an established modality for patients with selected high-risk locally advanced head and neck cancers. The optimal treatment of unknown primary squamous cell cancer of the head and neck (SCCHN) continues to be controversial, since m
## Abstract The success of organ preservation protocols in laryngeal cancer has led to an increase in the use of primary chemoradiation in both laryngeal and extralaryngeal sites, despite a paucity of randomized controlled clinical trial data comparing nonoperative treatment to the gold standard of
Squamous cell carcinoma of the head and neck (SCCHN) has traditionally been treated with a combination of surgery, chemotherapy, and external beam radiotherapy. While cure is generally the goal of these therapeutic modalities, recurrence is an unfortunately common outcome. Salvage surgery often resu